EUVIMEDOpdag EUVIMED
FallberichtOpen access · CC BY 4.0

Treatment of [ 99mTc ]Tc‐hydroxy‐diphosphonate ([ 99mTc ]Tc‐ HDP ) extravasation using hyaluronidase

Kevin R Doornhof iD, Quido de Lussanet de la Sablonière iD, Stijn L W Koolen iD, Mark W Konijnenberg iD

Pharmacology Research & Perspectives · 2024

DOI: 10.1002/prp2.1232 ↗

At a glance

Fallbericht in Pharmacology Research & Perspectives, 2024. Written by Kevin R Doornhof and 3 co-authors. Institution: Department of Radiology and Nuclear Medicine, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands. Major MEDLINE topics: Extravasation of Diagnostic and Therapeutic Materials, Hyaluronoglucosaminidase, Radiopharmaceuticals. 10 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Extravasation of 99mTc‐labeled radiopharmaceuticals is generally considered to require no specific intervention. In the presented case, the use of hyaluronidase could have minimized the adverse effects resulting from such an extravasation. Currently, no guidelines exist regarding the use of hyaluronidase after extravasation of [99mTc]Tc‐HDP. Considering the low risk of administering hyaluronidase, it should be considered to limit the risk of injury after extravasation of [99mTc]Tc‐HDP.

Subjects

MeSH terms (MEDLINE)

Extravasation of Diagnostic and Therapeutic MaterialsHyaluronoglucosaminidaseRadiopharmaceuticalsHumansOrganotechnetium CompoundsTechnetium Tc 99m Medronate

Author keywords

bone scintigraphyextravasationradiology [99mTc]Tc‐HDP

Substances

HyaluronoglucosaminidaseOrganotechnetium CompoundsRadiopharmaceuticalstechnetium Tc 99m hydroxymethylene diphosphonateTechnetium Tc 99m Medronate

Authors and institutions

  • Department of Radiology and Nuclear Medicine, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.

ORCID profiles: Kevin R Doornhof, Quido de Lussanet de la Sablonière, Stijn L W Koolen, Mark W Konijnenberg

Cite

APA

Doornhof, K. R., de Lussanet de la Sablonière, Q., Koolen, S. L. W., & Konijnenberg, M. W. (2024). Treatment of [ 99mTc ]Tc‐hydroxy‐diphosphonate ([ 99mTc ]Tc‐ HDP ) extravasation using hyaluronidase. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.1232

Vancouver

Doornhof KR, de Lussanet de la Sablonière Q, Koolen SLW, Konijnenberg MW. Treatment of [ 99mTc ]Tc‐hydroxy‐diphosphonate ([ 99mTc ]Tc‐ HDP ) extravasation using hyaluronidase. Pharmacology Research & Perspectives. 2024. doi:10.1002/prp2.1232

BibTeX
@article{Doornhof2024,
  author = {Doornhof, Kevin R and de Lussanet de la Sablonière, Quido and Koolen, Stijn L W and Konijnenberg, Mark W},
  title = {Treatment of [ 99mTc ]Tc‐hydroxy‐diphosphonate ([ 99mTc ]Tc‐ HDP ) extravasation using hyaluronidase},
  journal = {Pharmacology Research & Perspectives},
  year = {2024},
  doi = {10.1002/prp2.1232}
}
Start for free →